Abstract
Purinergic receptors have been shown to be involved in neuronal development, but the functions of specific subtypes of P2 receptors during neuronal development remain elusive. In this study we investigate the distribution of P2X7 receptors (P2X7Rs) in the embryonic rat brain using in situ hybridization. At E15.5, P2X7R mRNA was observed in the ventricular zone and subventricular zone, and colocalized with nestin, indicating that P2X7R might be expressed in neural progenitor cells (NPCs). P2X7R mRNA was also detected in the subgranular zone and dentate gyrus of the E18.5 and P4 brain. To investigate the roles of P2X7R and elucidate its mechanism, we established NPC cultures from the E15.5 rat brain. Stimulation of P2X7Rs induced Ca2+ influx, inhibited proliferation, altered cell cycle progression and enhanced the expression of neuronal markers, such as TUJ1 and MAP2. Similarly, knockdown of P2X7R by shRNA nearly abolished the agonist-stimulated increases in intracellular Ca2+ concentration and the expression of TUJ1 and NeuN. Furthermore, stimulation of P2X7R induced activation of ERK1/2, which was inhibited by the removal of extracellular Ca2+ and treatment with blockers for P2X7R and PKC activity. Stimulation of P2X7R also induced translocation of PKCα and PKCγ, but not of PKCβ, whereas knockdown of either PKCα or PKCγ inhibited ERK1/2 activation. Inhibition of PKC or p-ERK1/2 also caused a decrease in the number of TUJ1-positive cells and a concomitant increase in the number of GFAP-positive cells. Taken together, the activation of P2X7R in NPCs induced neuronal differentiation through a PKC-ERK1/2 signaling pathway.
Similar content being viewed by others
Main
The determination of neuronal and glial fate during CNS development involves complex interactions of intrinsic signals through many transcription factors.1 Neural stem cells (NSCs) have been considered as primary progenitor cells that lead to the formation of neuronal or glial cell lineages during development.2 NSCs are multipotent stem cells that exist in prenatal and early postnatal stages in two zones, the ventricular zone (VZ) and the subventricular zone (SVZ).3 NSCs develop into immediate progeny that are known as neural progenitor cells (NPCs),4 which have limited self-renewal capacity, behave as transient amplifying cells and have a higher rate of differentiation compared with NSCs.5
Growth and proliferation of NPCs require short-range autocrine/paracrine signals and the NPCs to be in close contact with one another. It has been suggested that one such short-range pathway is the ATP signaling. Purinergic receptors have been classified into two major families: P2Y and P2X receptors. Purinergic receptors have been shown to express in the early embryonic brain and have a role in embryogenesis.6 ATP acts as a proliferation signal for NPCs and also as a negative regulator of terminal neuronal differentiation through P2Y receptors.7 In addition, ATP has been shown to promote cell–cell communication and embryogenesis via stimulation of increases in intracellular Ca2+ concentration ([Ca2+]i).8, 9 ATP has also been found to enhance proliferation by elevating [Ca2+]i in olfactory epithelium.10 Thus, ATP-mediated Ca2+ signaling may have a crucial role in neurogenesis through regulation of differentiation, migration and cell fate determination.
Unlike other P2X receptor subtypes, the P2X7 receptor (P2X7R) has a short intracellular N-terminal domain, two transmembrane domains and a long C-terminal domain.11 Activation of P2X7Rs is known to induce Ca2+ influx and gliotransmitter release in astrocytes.12, 13 Expression of P2X7Rs has been identified in neurons and activation of the receptor results in glutamate-mediated excitation.14 P2X7Rs can be found in growth cones and can modulate neurotransmitter release in neurons.15 Recent studies have shown that the inhibition of P2X7R improves recovery after spinal cord injury and promotes axonal growth in hippocampal neurons.16, 17 Thus, P2X7Rs may have an important role in neuronal growth and regeneration.
Although the transcriptional and epigenetic factors involved in determination of NPCs fate have been well characterized, P2X7R-mediated extracellular cues in NPCs remain unexamined. A previous report indicated that the expression of P2X7Rs was found from E14 onward in rat embryos and triggered Ca2+ wave in the VZ of E16 brain.6, 18 Adult NPCs have also been found to express P2X7Rs, and their stimulation evoked an inward current and membrane depolarization.19 In this study we investigate the expression of P2X7Rs in E15, E18 and P4 rat brain, and examine the mechanism involved in the P2X7R-mediated neuronal differentiation of NPCs established from the E15.5 rat brain. We demonstrated that P2X7R is expressed in VZ and SVZ of the E15, E18 and P4 rat brain, and that stimulation of the receptors on the NPCs induces neuronal differentiation via the PKC-ERK1/2 signaling pathway.
Results
P2X7R RNA is expressed in the developing rat brain
In the present study we examined the expression of P2X7R mRNA using in situ hybridization (ISH) and the expression of neuronal markers using immunohistochemistry (IHC). Our preliminary results revealed that P2X7R mRNA was predominantly expressed in the cerebral cortex, basal ganglia and thalamus in the E15.5 rat brain (Supplementary Figure 1A); therefore, we focused our analysis on these areas. As shown in Figure 1a, enrichment of P2X7R mRNA was observed in the VZ and SVZ of the E15.5 rat brain and colocalized with nestin expression in these areas. P2X7R mRNA expression was also found to colocalize with TUJ1 expression in the SVZ of the E15.5 brain (Figure 1b). However, in the E18.5 (Figure 1c) and P4 (Figure 1d) rat brains, few nestin-positive cells were observed to colocalize with P2X7R mRNA in the VZ. Furthermore, P2X7R mRNA colocalized with nestin in the E18.5 hippocampus (Figure 1e) and colocalized with TUJ1 in CA1 and CA3, as well as in the granule cell layer and subgranular zone (SGZ) of dentate gyrus (DG) in the hippocampus at P4 (Figure 1f). Higher-magnification microscopic analysis revealed that P2X7R mRNA expression was more abundant in the cortical cells of the P4 brain than that of E15.5 brain (Figure 1g). These results showed that P2X7R mRNA is generally expressed in nestin-positive NPCs in the developing rat brain. Our results further showed that P2X7R mRNA is also expressed in terminally differentiated neural cells at E18.5.
P2X7R negatively regulates NPC proliferation
To further investigate the roles of P2X7Rs in VZ and SVZ, we established NPC cultures using cells isolated from the E15.5 rat brain. RT-PCR analysis revealed that these cells expressed P2X7R mRNA (Figure 2a). Ca2+ imaging analysis revealed that a potent P2X7R agonist, BzATP, stimulated increase in [Ca2+]i (Figure 2b) that was abolished by the removal of Ca2+ in the medium and was inhibited by the selective P2X7R antagonists, A438079, oxidized ATP (oATP), Brilliant Blue G (BBG) and calmidazolium (Figure 2c). Thus, BzATP might stimulate Ca2+ influx through P2X7R. RT-PCR analysis indicated NPCs also express other P2 receptors and a higher concentration of ATP-stimulated increases in [Ca2+]i (Supplementary Figures 2A and B). To ascertain that the BzATP did not activate other P2 receptors of NPCs, we measure Ca2+ response in the presence of P2X, P2X4R, P2Y1R, P2YR, and P2X1–6R antagonists, PPADS, 5BDBD, MRS2179, suramin and TNP-ATP respectively. The results revealed that only PPADS inhibited BzATP-stimulated Ca2+ signal (Supplementary Figure 2C). This demonstrated that BzATP only activates P2X7R in NPCs. In addition, treatment of the NPC cultures with BzATP (1–100 μM) for 4 days decreased the cell number dose dependently (Figure 2d). The BzATP treatment also decreased 5-bromo-2′-deoxyuridine (BrdU) incorporation of the spheres, and the statistical analyses revealed this decrease was dose dependent (Figure 2e). We conducted TUNEL assays to investigate whether the decreases in BrdU incorporation might be due to cell death. BzATP did not induce cell death compared with the controls, suggesting that the reduction in cell number could not be attributed to apoptosis (Supplementary Figure 3A). Flow cytometry analysis further revealed that BzATP treatment had no effect on the sub-G1 phase (Supplementary Figure 4A) but altered cell cycle progression by decreasing cells in the G0/G1 and G2 phases, and increased the number of cells in the S phases of these cells (Figure 2f). Thus, activation of P2X7R induced a negative regulation of proliferation and might increase the neuronal differentiation of NPCs.
Stimulation of P2X7R enhances the neuronal differentiation of NPCs
To examine whether the activation of P2X7R induces the neuronal differentiation of NPCs, we analyzed the BzATP-stimulated TUJ1 expression via western blot analysis. Our preliminary analysis revealed that BzATP treatment induced increases in the TUJ1 expression, and a statistically significant increase was observed at day 7 (Figure 2g). We therefore analyzed NPC and neuronal marker expression by treating NPCs with 50 μM BzATP for 7 days. We first stained the dispersed naive NPCs for GFAP and nestin expression. As shown in Figure 3a, the dispersed NPCs stained intensely for GFAP and nestin, but much more weakly for TUJ1 and MAP2. Treatment of BzATP enhanced the expression of TUJ1 and MAP2 (Figure 3b). The BzATP-enhanced expression of TUJ1 and MAP2 was inhibited by the P2X7R antagonists, oATP (Figure 3c) and A438079 (Figure 3d). The statistical analysis showed that BzATP treatment decreased the numbers of nestin-positive cells and enhanced the TUJ1- and MAP2-positive cells, and its effects were significantly inhibited by A438079, oATP and BBG (Figure 3e). Furthermore, real-time PCR analysis confirmed that BzATP treatment decreased the mRNA expression of NPCs markers, such as Wnt7a, msi1 and GFAP, but enhanced the expression of neuronal cell markers, such as doublecortin and neuronal-specific enolase (Figure 3f). Thus, activation of P2X7Rs is likely to enhance neuronal differentiation of NPCs.
To determine whether P2X7R is involved in the neuronal differentiation of NPCs, we used an shRNA knockdown assay. Full-length P2X7R was cloned using mRNA isolated from the NPCs and expressed in HEK293T cells. The shRNAs, sR-1133 and sR-135, decreased the P2X7R mRNA expression in HEK293T-P2X7R cells (Figure 4a). The shRNAs were infected into NPCs, and we then examined the BzATP-stimulated Ca2+ signaling with Ca2+ imaging analysis. The statistical analysis of the Ca2+ signaling showed that sR1133 and sR-135, but not the scrambled shRNA, significantly blocked the BzATP-induced Ca2+ signaling (Figure 4b). We then used immunocytochemical (ICC) to examine the expression of cell markers in these cells. sR-1133 and sR-135, but not sR-Scramble or sR-LacZ, decreased TUJ1 and NeuN expression in the BzATP-treated NPCs and a concomitant increase in nestin and GFAP expression (Figures 4c–f). Thus, we concluded that activation of P2X7R is involved in neuronal differentiation of NPCs.
The PKC/ERK1/2 pathway regulates NPC differentiation mediated by P2X7R
It is known that the stimulation of P2X7R induces Ca2+ influx20, 21 and the activation of the Ca2+-dependent PKC and ERK1/2.12, 22 In the present study, the time-course analysis revealed that BzATP triggered a rapid ERK1/2 activation that peaked at 3 min and returned to base line levels at 15 min (Figure 5a). The statistical analysis revealed that BzATP triggered a 10-fold increase in p-ERK1/2 (Figure 5b). This effect was blocked by removal of extracellular Ca2+ and A438079 (Figures 5c and d). To further examine the components of upstream signaling in ERK1/2 activation, we inhibited MEK, CaMKII, PKC and PI3K, with PD98059, KN93, GF109203X and LY294002, respectively. As shown in Figure 5e, p-ERK1/2 was inhibited by GF109203X and PD98059, but not by KN93 or LY294002. The statistical analysis demonstrated that PD98059 and GF109203X significantly inhibited the BzATP-stimulated ERK1/2 activation (Figure 5f). Together, these results indicated PKC and MEK, but not CaMKII or PI3K, are involved in the P2X7R-mediated ERK1/2 activation, and Ca2+-dependent PKC isozymes may be the upstream signaling to ERK1/2.
We next examined the BzATP-induced translocation of the Ca2+-dependent PKC subtypes. BzATP stimulated increases in the membrane fractions of PKCα and PKCγ but not PKCβ in NPCs (Figure 6a). The statistical analysis revealed that BzATP decreased PKCα and PKCγ but not the PKCβ expression in the cytosolic fraction (Figure 6b), with concomitant increase in membrane fraction (Figure 6c). To ascertain whether PKCα and PKCγ are involved in the ERK1/2 signaling pathway, we used an shRNA knockdown assay. sR-PKCα and sR-PKCγ decreased the expression of PKCα and PKCγ, respectively (Figure 6d). The statistical analysis revealed that sR-PKCα and sR-PKCγ blocked an ∼70 and 60% of ERK activation, respectively (Figure 6e). Thus, both PKCα and PKCγ were involved in P2X7R-mediated activation of ERK. To confirm that PKC and ERK1/2 signaling cascade is involved in P2X7R-mediated neuronal differentiation of NPCs, the NPCs were treated with BzATP for 7 days and the number of TUJ1-positive cells was counted. Treatment with either GF109203X or PD98059 partially blocked the BzATP-induced increase in TUJ1-positive cells and increased the number of GFAP-positive cells (Figure 7a). The statistical analysis revealed that effects of PD98059 and GF109203X on BzATP-induced changes in TUJ1 and GFAP expression were significant (Figure 7b). Thus, PKC-ERK1/2 signaling is involved in P2X7R-mediated the neuronal differentiation of NPCs.
Discussion
A previous study showed that P2X7R mRNA is expressed from E14 onward in the rat brain.6 Similarly, we observed that P2X7R mRNA is expressed in the VZ and SVZ of the E15.5 rat brain. By using the E15.5 brain-derived NPC cultures, we further demonstrated that the potent P2X7R agonist BzATP stimulated Ca2+ signaling and induced the neuronal differentiation of these cells. Thus, functional P2X7Rs are expressed in NPC-enriched areas of the embryonic brain.
During development, neuronal differentiation begins at E11.5, peaks at ∼E14 and continues at lower levels until E17.5.23 Our data showed that P2X7R mRNA was expressed in the proliferating NPCs of the VZ and SVZ of the E15.5 rat brain. As development proceeded, the P2X7R-expressing differentiating cells moved outwards through the intermediate zone to the cortical plate area. A high level of P2X7R mRNA was observed in the cortical plate area, possibly due to rapid increases in P2X7R-expressing glial cells in vivo starting at E17 (Supplementary Figure 1B). However, P2X7R mRNA was also observed in the SVZ and VZ, and throughout the layers of the hippocampus, including the CA1 and CA3 regions, and the SGZ of DG at P4. In adulthood, there is continuous production of new neurons that migrate from the SGZ to the adjacent granule cell layer of the DG.24 Our results showed the presence of P2X7R mRNA in the DG from E18.5 to adulthood and P2X7R mRNA colocalized with a marker of immature neurons. This suggests that P2X7R expression may be associated with neuronal growth from embryonic stages through adulthood. Recently, P2X7R mRNA was found to be expressed in neurons of the adult rat hippocampus to regulate neurotransmitter release.25 Our results are consistent with the findings that P2X7Rs are expressed in neurons in the hippocampal area and other regions of the brain.14, 17, 26, 27
ATP signaling has been shown to occur during development, both at early stages, such as gastrulation and germ layer definition, and in the late stages of neural development.28, 29 P2X7R expression was initially identified in glial cells in the CNS20, 30, 31 and was functionally linked to cytokines and gliotransmitter release.12, 32 Our group showed that P2X7R is involved in proliferation, whereas inhibition and knockdown of the receptor induced neuronal differentiation of N2a neuroblastoma cells.33 It is known that activation of P2X7R induces a sustained increase in [Ca2+]i through Ca2+ influx. Therefore, P2X7R may act as a mechanism to regulate [Ca2+]i and control a diverse range of Ca2+-mediated cellular functions. Until now, the roles of cellular ATP signaling and P2X7R in NPCs have remained unexamined. It has been shown that ATP release via hemichannels in retinal pigment epithelium evoked spontaneous elevations of [Ca2+]i in retinal progenitor cells and in the developing brain.9, 29 Therefore, ATP release may act as an autocrine signal to activate P2X7R and induce Ca2+ influx, altering cellular function during development.
It is accepted that ATP is a neurotransmitter in the both central and peripheral nervous systems. ATP is also known to act as a regulator in glia-neuron communication and regulate synaptic transmission and plasticity.34 ATP is released from nerve terminals via exocytosis and from non-neuronal cells via various mechanisms.35 Presumably, ATP may be released from the NPCs or the neighboring cells to activate P2X7R and other purinergic receptors during development. Our preliminary results showed that NPCs possess several purinergic receptors and that ATP stimulated increases in [Ca2+]i in these cells (Supplementary Figures 5A and B). Therefore, ATP might activate signaling downstream of Ca2+ influx, perhaps through the conventional PKC isozymes in NPCs.
PKC isozymes have been shown to act as upstream regulators of MAPKs.36, 37 Our early results have shown that the stimulation of P2X7R activated PKC and ERK1/212, 30 and induced the interaction of PKCγ with P2X7R in astrocytes.38 Similarly, we found that stimulation of P2X7R activated the conventional PKC isozymes PKCα and PKCγ, but not PKCβ, and also activated ERK1/2, but not PI3K and CAMKII, in NPCs. Stimulation of P2X7R was shown to activate a CAMKII-related pathway and to negatively regulate axon17 and neurite growth.39 Recently, stimulation of P2X7R induced translocation of PKC-β1 in mouse alveolar epithelial E10 cells.40 Thus, activation of P2X7R may also activate different intracellular signaling mechanisms to regulate distinct cellular functions in various types of cells.
Prolonged stimulation of P2X7R induces the formation of a non-selective pore and leads to cell death.41, 42 The stimulation of P2X7R in E14.5 NPCs induced cell death in the absence of pore formation.43 In the present study, the stimulation of P2X7R in E15.5 NPCs triggered neither pore formation nor cell death but did induce neuronal differentiation (Supplementary Figure 5). P2X7R was identified to have survival- and growth-promoting effects in certain cancer cells.44 In contrast, our earlier result demonstrated that inhibition or knockdown of P2X7R induced neuronal differentiation of N2a neuroblastoma cells.33 The stimulation of the P2X7R-expressing HEK293 cells increased cell survival in serum-free conditions.45 Thus, stimulation of P2X7R may lead to alterations of different physiological functions in different types of cells. This specificity may also be due to different isoforms of P2X7R. Several single-nucleotide polymorphisms with alterations in pathophysiological functions have been identified in human P2X7Rs.46, 47 At least two splice variant isoforms have been identified in mice.48, 49 The P2X7 (k) variant was identified to be constitutively dilated and highly sensitive to agonist BzATP, and escaped gene deletion in one of the P2X7R knockout mouse strains.48 A recent report also indicated that the ΔC variant is inefficiently trafficked to the cell surface and has little agonist-evoked current.50 Thus, there are apparent functional and physiological differences between the wild-type receptor and the variants. It is possible that the rat E15.5 NPCs express more than one P2X7R isoform. Further identification of P2X7R isoforms and their physiological functions in NPCs are needed.
NPCs transplantation has been used to deliver therapeutic genes directly to the mouse brain to correct metabolic diseases.51 The present study not only provides a system to understand the role of P2X7R in brain development but also identifies a signaling pathway with possible therapeutic target sites.
Materials and Methods
Animal tissue preparation
All the experimental animals were approved by the laboratory animal center of the National Yang Ming University (Taipei, Taiwan). The pups were perfused with 0.9% NaCl, followed by fixation with 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS). The brains were dissected, post-fixed with the same fixative solution for 8 h at 4 °C and then dehydrated in 30% sucrose at 4 °C overnight. All solutions were sterile-filtered and treated with 0.1% diethyl pyrocarbonate. Brain sections were cut into 10-μm slices with a Leica 3050S (Leica Biosystems, Wetzlar, Germany) and were stored at −80 °C until use. For each experiment, at least three animals were used for each development stage.
Isolation and propagation of embryonic NPCs
Embryonic NPCs were grown according to the method described previously, with modifications.52 Cells were dissociated from the midbrain and telencephalon without striatum of the E15.5 Sprague–Dawley rat brain and cultured in DMEM/F12 supplemented with N2 (Life Technologies, Frederick, MD, USA),53 epidermal growth factor (20 ng/ml), basic fibroblast growth factor (10 ng/ml; PeproTech, Rocky Hill, NJ, USA), heparin (5 μg/ml; Sigma-Aldrich, St. Louis, MO, USA) and 50 U/ml penicillin. Neurospheres appeared after 1 week in culture. Medium was replaced every 3 days with gentle trituration, and the spheres were further cultured for 1 month. The cultures were then stained with nestin for the identification of NPCs; 95% of the cells were nestin-positive. After treatment with BzATP (0, 1, 10, 25, 50 and 100 μM) for 4 days, the spheres were mechanically dissociated into single cell, mixed with 0.1% Trypan Blue solution (1:1) and counted immediately with a hemocytometer.
In vitro differentiation, cell cycle progress and cell death assay
To induce differentiation, cells were cultured in DMEM/F12 supplemented with N2 supplement and 0.5% FBS for 2 days.54, 55 Then, fresh differentiation medium with P2X7R agonist, BzATP, was provided for 7 days. To assay for cell cycle progression, neurospheres were dissociated into single-cell suspension and were fixed in 70% (v/v) ethanol at 4 °C for 1.5 h, washed twice with PBS and were stained with propidium iodide (PI) solution (50 μM ribonuclease A, 4 μM PI, 0.1% Triton X-100 in PBS) for 30 min in the dark. Then, cells were assayed with a flow cytometer (FACSCalibur; BD Biosciences, San Diego, CA, USA) and the results were analyzed using FCS Express software (De Novo Software, Los Angeles, CA, USA). To assay for cell death, cells were fixed with PFA and analyzed for TUNEL-stained nuclei using a TUNEL kit (Roche, Basel, Switzerland) according to the manufacturer’s instructions.
Immunofluorescence staining
For IHC staining, brain sections were treated with 0.1% Triton X-100 in PBS for 20 min, incubated in PBS containing 2% goat serum and 3% horse serum for 1 h, and then incubated with primary antibodies in blocking solution at 4 °C overnight. An ICC analysis was also performed by fixing NPCs in 4% PFA for 20 min, treating with 0.1% Triton X-100 in PBS for 20 min and incubating with primary antibodies at 4 °C overnight before incubation in blocking solution for 1 h. After rinsing three times, the sections or cells were incubated with secondary antibodies conjugated to fluorescein and Texas red (1:200; all from Vector Laboratories) for 2 h and then incubated with 4′-6-diamidino-2-phenylindole (DAPI) for 15 min. Fluorescence signals were detected with a FV300 confocal imaging system (Olympus Japan, Tokyo, Japan). Cell numbers were quantified using NIH ImageJ software. Primary antibodies and dilutions were as follows: GFAP (1:1000; DAKO, Glostrup, Denmark), Nestin (1:200; Millipore, Bedford, MA, USA), NeuN (1:200; Chemicom, Temecula, CA, USA), MAP2 (1:300; Chemicom) and β-tubulin type III monoclonal (TUJ1, 1:1000; Promega, Southampton, UK).
In vitro transcription
The P2X7R probe was cloned into pGEM T-easy vector (Promega) for the antisense and sense riboprobe synthesis. The non-radioactive riboprobes were synthesized by in vitro transcription using T7 and SP6 polymerase (Promega), respectively, and were labeled with digoxigenin-labeling mix (Roche). Before hybridization, the riboprobes were diluted with the hybridization buffer to 2 ng/μl and denatured at 65 °C for 10 min. A 119 bp cDNA fragment of the P2X7R corresponds to bases from 1258 to 1376 (numbering a according to GenBank accession number no. X95882).
ISH of P2X7R mRNA expression
Brain sections were fixed with 4% PFA, treated with 0.2 N HCl and l μg/ml protease K, and then incubated with prehybridization buffer containing 50% formamide and 2 × SSC at 60 °C for 90 min. The sections were hybridized with digoxigenin-labeled riboprobes in hybridization buffer (10% dextran sulfate, 50% formamide, 1 mM EDTA, 318 mM NaCl, 10.6 mM Tris, 1 × Denhardt’s solution, 500 μg/ml tRNA and 10 mM DTT) at 60 °C for 16 h, washed with 50% formamide in 2 × SSC at 60 °C for 1 h, 20 μg/ml RNaseA for 30 min, and then washed sequentially with 2 × SSC and 0.2 × SSC at 60 °C for 20 min. The sections were blocked with 2% blocking reagent containing 8% sheep serum in TNT buffer (100 mM Tris, pH 7.5, 150 mM NaCl and 0.05% Tween-20) for 1 h. The endogenous peroxidases were inhibited with 0.3% H2O2 in PBS for 10 min and the sections were then incubated with POD-conjugated sheep anti-digoxigenin antibody (1:1000, Roche) for 3 h. After washing with TNT buffer twice, the signals were detected by using TSA PLUS Fluorescence Kits (1:700, PerkinElmer, Norwalk, CT, USA).
Protein fractionation, immunohistology analysis and western blot
For western blot analysis, proteins were extracted by scraping the NPCs in homogenate buffer (320 mM sucrose, 1 mM EDTA, 50 mM Tris-HCl, 1 mM PMSF and 1 × proteinase inhibitor). After homogenation on ice, cell lysates were cleared by centrifugation at 1000 × g in a microcentrifuge (Kubota, Tokyo, Japan) for 10 min at 4 °C. The supernatant were then centrifuged at 100 000 × g in a desktop ultracentrifuger (Beckman Coulter, Fullerton, CA, USA). The cytosolic fraction was taken from the supernatants after centrifugation and the membrane fraction from the pellets was lysed in lysis buffer (20 mM HEPES, 1% Triton X-100, 10 mM NaF, 1 mM Na3VO4, 1 mM PMSF). Aliquots of proteins (20 μg) proteins were separated by 10% SDS-PAGE, transferred onto PVDF membrane and incubated overnight with 5% BSA in PBS. The membranes were incubated with primary antibodies, followed by hybridized with the HRP-conjugated secondary antibody (1:10000; Vector Laboratories). The membranes were reacted with Luminata Western HRP Substrates (Millipore) and detected with a digital image system (ImageQuant LAS 4000; Fujifilm Lifescience, Tokyo, Japan). The primary antibodies contained phospho-p44/42 MAPK (p-ERK1/2; 1:400), p44/42 MAPK (ERK1/2; 1:200) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH; 1:1000), purchased from Cell Signaling Technology (Danvers, MA, USA). PKCα (1:500), PKCβ (1:250), PKCγ (1:500) and flotillin (1:1000) antibodies were purchased from BD Biosciences.
Reverse-transcription PCR
Total RNA was extracted from NPCs with 1 ml of Rezol reagent (Protech Technologies, Taipei, Taiwan). One milligram of total RNA was reverse-transcribed using Superscript III reverse transcriptase (Life Technologies) in 20 μl at 42 °C for 1 h according to the manufacturer’s protocol. Primer 3 software (http://frodo.wi.mit.edu) was used to design oligonucleotide primers spanning intron sequences, and these primers are listed in Table 1.
Quantitative real-time PCR
Real-time PCR analyses were performed on the Rotor-Gene 3000 (Qiagen, Valencia, CA, USA) using the SYBR Fast One-Step qRT-PCR Kit (Kapa Biosystems, Woburn, MA, USA) and the manufacturer’s protocol. Specific primers were designed by Primers 3 software and are listed in Table 1. The melting curve detected a single melt peak and PCR efficiency values between 90 and 110% for all amplicons. Relative gene expression levels were then normalized to GAPDH expression in each sample.
BrdU incorporation assay
The BrdU incorporation assay was performed by using the Cell Proliferation BrdU kit (Roche). After the experiment, the cells were labeled with a 10 mM BrdU solution and incubated for 8 h at 37 °C, washed with PBS, fixed with FixDenat for 30 min and incubated in 1 N HCl for 10 min at 4 °C. The cells were then washed with PBS with 1% Triton X-100, neutralized with 0.1 M Na2B4O7 for 12 min and then blocked with 2% goat serum for 1 h. After rinsing with PBS, the cells were incubated with anti-BrdU-POD antibody (1:300) for 2 h, and the signals were detected with TSA PLUS Fluorescence kits.
Construction of expression plasmids
The pGEM-P2X7 plasmid was constructed by inserting the full fragment of the rat P2X7R sequence (number X95882) into the pGEM-T Easy vector (Promega). The primer is listed in Table 1. The fragments were generated by HiFi DNA polymerase (Yeastern Biotech, Shijr, Taiwan). The conditions were as follows: denaturation at 94 °C for 1 min followed by 30 cycles of denaturation at 94 °C for 15 s, annealing at 60 °C for 30 s and extension at 68 °C for 2 min followed by at 68 °C for 5 min. The products were cloned into a pGEM T-easy vector, and then the plasmid DNA was transfected into HEK293T cells with the Lipofectamine 2000 transfection method according to the manufacturer’s procedure (Life Technologies). HEK293T cells were grown in DMEM (Life Technologies) medium with 10% FBS.
shRNA knockdown
shRNA targeting P2X7R mRNA was purchased from Biosettia (San Diego, CA, USA). The sequences are as follows: non-specific shRNA (sR-LacZ) 5′-GCAGTTATCTGGAAGATCAGG-CCTGATCTTCCAGATAACTGC-3′, sh-P2X7–135 (sR-135) 5′-GCAGCTGGAACGATGTCTTTC-GAAAGACATCGTTCCAGCTGC-3′, sh-P2X7–1133 (sR-1133) 5′-GGATCCACCCTGTCCTATTTC-GAAATAGGACAGGGTGGATCC-3′ and sh-P2X7-scramble shRNA (sR-Scramble) 5′-GCTACACTATCGAGCAATT-AATTGCTCGATAGTGTAGC-3′. All shRNA sequences have 5′-TTGGATCCAA-3′ in the sequence for the short-hairpin loop. The pLV-RNAi vector contains a mouse U6 promoter-driven shRNA coding sequence followed by a CMV-driven EGFP reporter. HEK293T cells expressing pGEM-P2X7 plasmid or NPCs were infected with sR-Scramble, sR-1133, sR-LacZ or sR-135, and the desired virus titer was reached when cells were infected at an MOI of 0.5. PKCα and PKCγ shRNA clones were obtained from the National RNAi Core Facility (Genomics Research Center, Academia Sinica, Taiwan). shRNA against the target sequence was sR-PKCα for mouse PKCα (clone ID TRCN0000235973) and sR-PKCγ for human PKCγ (TRCN0000199230).
Ca2+ image analysis
Cells were grown on 24-mm coverslips and were incubated with loading buffer (125 mM NaCl, 5 mM KCl, 1.8 mM CaCl2, 2 mM MgCl2, 0.5 mM NaH2PO4, 5 mM NaHCO3, 10 mM HEPES and 10 mM glucose, pH 7.4) containing 1 μg/ml Fura-2 AM (Life Technologies) for 40 min at 37 °C in the dark. Ca2+ imaging analysis was performed using excitation wavelengths (340/380 nm) selected by means of a computer-controlled rotating filter wheel between a xenon light source and the microscope. The resulting image at each wavelength was averaged in real time, digitalized and stored in an image-processing unit. The results were calculated using a Metafluor image analysis system (Universal Imaging Corporation, Philadelphia, PA, USA). Statistical analysis was conducted after the calculation of changes in fluorescence (ΔF) and expressed as percentage of the average baseline fluorescence (F) (%ΔF/F).56
Statistical analysis
All statistical analyses were performed using SAS Version 9.1.3 (SAS Institute, Cary, NC, USA) and SigmaPlot XII Software (Systat Software, San Jose, CA, USA). Results are represented as the mean±S.D. and the symbol * indicates significantly different means (P<0.05) as analyzed by a nonpaired Student’s t-test or one-way ANOVA with Bonferroni’s post-hoc test. The Mann–Whitney’s U-test with nonparametric distribution was used to compare peak values of Ca2+.
Accession codes
Abbreviations
- NPC:
-
neural progenitor cell
- SVZ:
-
subventricular zone
- P2X7R:
-
P2X7 receptor
- oATP:
-
oxidized ATP
References
Edlund T, Jessell TM . Progression from extrinsic to intrinsic signaling in cell fate specification: a view from the nervous system. Cell 1999; 96: 211–224.
Rietze RL, Valcanis H, Brooker GF, Thomas T, Voss AK, Bartlett PF . Purification of a pluripotent neural stem cell from the adult mouse brain. Nature 2001; 412: 736–739.
Pencea V, Luskin MB . Prenatal development of the rodent rostral migratory stream. J Comparative Neurol 2003; 463: 402–418.
Götz M, Huttner WB . The cell biology of neurogenesis. Nat Rev Mol Cell Biol 2005; 6: 777–788.
Kempermann G, Jessberger S, Steiner B, Kronenberg G . Milestones of neuronal development in the adult hippocampus. Trends Neurosci 2004; 27: 447–452.
Cheung KK, Chan WY, Burnstock G . Expression of P2X purinoceptors during rat brain development and their inhibitory role on motor axon outgrowth in neural tube explant cultures. Neuroscience 2005; 133: 937–945.
Lin JH, Takano T, Arcuino G, Wang X, Hu F, Darzynkiewicz Z et al. Purinergic signaling regulates neural progenitor cell expansion and neurogenesis. Dev Biol 2007; 302: 356–366.
Salter MW, Hicks JL . ATP causes release of intracellular Ca2+ via the phospholipase C beta/IP3 pathway in astrocytes from the dorsal spinal cord. J Neurosci 1995; 15: 2961–2971.
Pearson RA, Dale N, Llaudet E, Mobbs P . ATP released via gap junction hemichannels from the pigment epithelium regulates neural retinal progenitor proliferation. Neuron 2005; 46: 731–744.
Hassenklöver T, Schwartz P, Schild D, Manzini I . Purinergic signaling regulates cell proliferation of olfactory epithelium progenitors. Stem Cells 2009; 27: 2022–2031.
Surprenant A, Rassendren F, Kawashima E, North RA, Buell G . The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 1996; 272: 735–738.
Wang CM, Chang YY, Sun SH . Activation of P2X7 purinoceptor-stimulated TGF-beta 1 mRNA expression involves PKC/MAPK signalling pathway in a rat brain-derived type-2 astrocyte cell line, RBA-2. Cell Signal 2003; 15: 1129–1137.
Iglesias R, Locovei S, Roque A, Alberto AP, Dahl G, Spray DC et al. P2X7 receptor-Pannexin1 complex: pharmacology and signaling. Am J Physiol Cell Physiol 2008; 295: C752–C760.
Deuchars SA, Atkinson L, Brooke RE, Musa H, Milligan CJ, Batten TF et al. Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems. J Neurosci 2001; 21: 7143–7152.
Miras-Portugal MT, Díaz-Hernández M, Giráldez L, Hervás C, Gómez-Villafuertes R, Sen RP et al. P2X7 receptors in rat brain: presence in synaptic terminals and granule cells. Neurochem Res 2003; 28: 1597–1605.
Peng W, Cotrina ML, Han X, Yu H, Bekar L, Blum L et al. Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury. Proc Natl Acad Sci USA 2009; 106: 12489–12493.
Díaz-Hernandez M, del Puerto A, Díaz-Hernandez JI, Diez-Zaera M, Lucas JJ, Garrido JJ et al. Inhibition of the ATP-gated P2X7 receptor promotes axonal growth and branching in cultured hippocampal neurons. J Cell Sci 2008; 121: 3717–3728.
Weissman TA, Riquelme PA, Ivic L, Flint AC, Kriegstein AR . Calcium waves propagate through radial glial cells and modulate proliferation in the developing neocortex. Neuron 2004; 43: 647–661.
Hogg RC, Chipperfield H, Whyte KA, Stafford MR, Hansen MA, Cool SM et al. Functional maturation of isolated neural progenitor cells from the adult rat hippocampus. Eur J Neurosci 2004; 19: 2410–2420.
Suadicani SO, Brosnan CF, Scemes E . P2X7 receptors mediate ATP release and amplification of astrocytic intercellular Ca2+ signaling. J Neurosci 2006; 26: 1378–1385.
Donnelly-Roberts DL, Namovic MT, Han P, Jarvis MF . Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors. Br J Pharmacol 2009; 157: 1203–1214.
Hung AC, Sun SH . The P2X7 receptor-mediated phospholipase D activation is regulated by both PKC-dependent and PKC-independent pathways in a rat brain-derived Type-2 astrocyte cell line, RBA-2. Cell Signal 2002; 14: 83–92.
Ghosh A, Greenberg ME . Distinct roles for bFGF and NT-3 in the regulation of cortical neurogenesis. Neuron 1995; 15: 89–103.
Zhao C, Deng W, Gage FH . Mechanisms and functional implications of adult neurogenesis. Cell 2008; 132: 645–660.
Sperlágh B, Köfalvi A, Deuchars J, Atkinson L, Milligan CJ, Buckley NJ et al. Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus. J Neurochem 2002; 81: 1196–1211.
Cho JH, Choi IS, Jang IS . P2X7 receptors enhance glutamate release in hippocampal hilar neurons. Neuroreport 2010; 21: 865–870.
del Puerto A, Díaz-Hernández JI, Tapia M, Gomez-Villafuertes R, Benitez MJ, Zhang J et al. Adenylate cyclase 5 coordinates the action of ADP, P2Y1, P2Y13 and ATP-gated P2X7 receptors on axonal elongation. J Cell Sci 2012; 125: 176–188.
Burnstock G, Ulrich H . Purinergic signaling in embryonic and stem cell development. Cell Mol Life Sci 2011; 68: 1369–1394.
Dale N . Dynamic ATP signalling and neural development. J Physiol 2008; 586: 2429–2436.
Sun SH, Lin LB, Hung AC, Kuo JS . ATP-stimulated Ca2+ influx and phospholipase D activities of a rat brain-derived type-2 astrocyte cell line, RBA-2, are mediated through P2X7 receptors. J Neurochem 1999; 73: 334–343.
Rappold PM, Lynd-Balta E, Joseph SA . P2X7 receptor immunoreactive profile confined to resting and activated microglia in the epileptic brain. Brain Res 2006; 1089: 171–178.
Sun SH . Roles of P2X7 receptor in glial and neuroblastoma cells: the therapeutic potential of P2X7 receptor antagonists. Mol Neurobiol 2010; 41: 351–355.
Wu PY, Lin YC, Chang CL, Lu HT, Chin CH, Hsu TT et al. Functional decreases in P2X7 receptors are associated with retinoic acid-induced neuronal differentiation of Neuro-2a neuroblastoma cells. Cell Signal 2009; 21: 881–891.
Fields RD, Burnstock G . Purinergic signalling in neuron-glia interactions. Nat Rev Neurosci 2006; 7: 423–436.
Bodin P, Burnstock G . Purinergic signalling: ATP release. Neurochem Res 2001; 26: 959–969.
Belcheva MM, Clark AL, Haas PD, Serna JS, Hahn JW, Kiss A et al. Mu and kappa opioid receptors activate ERK/MAPK via different protein kinase C isoforms and secondary messengers in astrocytes. J Biol Chem 2005; 280: 27662–27669.
Geraldes P, Hiraoka-Yamamoto J, Matsumoto M, Clermont A, Leitges M, Marette A et al. Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat Med 2009; 15: 1298–1306.
Hung AC, Chu YJ, Lin YH, Weng JY, Chen HB, Au YC et al. Roles of protein kinase C in regulation of P2X7 receptor-mediated calcium signalling of cultured type-2 astrocyte cell line, RBA-2. Cell Signal 2005; 17: 1384–1396.
Gómez-Villafuertes R, del Puerto A, Díaz-Hernández M, Bustillo D, Díaz-Hernández JI, Huerta PG et al. Ca2+/calmodulin-dependent kinase II signalling cascade mediates P2X7 receptor-dependent inhibition of neuritogenesis in neuroblastoma cells. FEBS J 2009; 276: 5307–5325.
Bläsche R, Ebeling G, Perike S, Weinhold K, Kasper M, Barth K . Activation of P2X7R and downstream effects in bleomycin treated lung epithelial cells. Int J Biochem Cell Biol 2012; 44: 514–524.
Virginio C, MacKenzie A, Rassendren FA, North RA, Surprenant A . Pore dilation of neuronal P2X receptor channels. Nat Neurosci 1999; 2: 315–321.
North RA . Molecular physiology of P2X receptors. Physiol Rev 2002; 82: 1013–1067.
Delarasse C, Gonnord P, Galante M, Auger R, Daniel H, Motta I et al. Neural progenitor cell death is induced by extracellular ATP via ligation of P2X7 receptor. J Neurochem 2009; 109: 846–857.
Thompson BA, Storm MP, Hewinson J, Hogg S, Welham MJ, MacKenzie AB . A novel role for P2X7 receptor signalling in the survival of mouse embryonic stem cells. Cell Signal 2012; 24: 770–778.
Adinolfi E, Callegari MG, Ferrari D, Bolognesi C, Minelli M, Wieckowski MR et al. Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth. Mol Biol Cell 2005; 16: 3260–3272.
Wiley JS, Dao-Ung LP, Li C, Shemon AN, Gu BJ, Smart ML et al. An Ile-568 to Asn polymorphism prevents normal trafficking and function of the human P2X7 receptor. J Biol Chem 2003; 278: 17108–17113.
Cabrini G, Falzoni S, Forchap SL, Pellegatti P, Balboni A, Agostini P et al. A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. J Immunol 2005; 175: 82–89.
Nicke A, Kuan YH, Masin M, Rettinger J, Marquez-Klaka B, Bender O et al. A functional P2X7 splice variant with an alternative transmembrane domain 1 escapes gene inactivation in P2X7 knock-out mice. J Biol Chem 2009; 284: 25813–25822.
Ohlendorff SD, Tofteng CL, Jensen JE, Petersen S, Civitelli R, Fenger M et al. Single nucleotide polymorphisms in the P2X7 gene are associated to fracture risk and to effect of strogen treatment. Pharmacogenet Genomics 2007; 17: 555–567.
Masin M, Young C, Lim K, Barnes SJ, Xu XJ, Marschall V et al. Expression, assembly and function of novel C-terminal truncated variants of the mouse P2X7 receptor: re-evaluation of P2X7 knockouts. Br J Pharmacol 2012; 165: 978–993.
Snyder EY, Taylor RM, Wolfe JH . Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature 1995; 374: 367–370.
Zhou FC, Kelley MR, Chiang YH, Young P . Three to four-year-old nonpassaged EGF-responsive neural progenitor cells: proliferation, apoptosis, and DNA repair. Exper Neurol 2000; 164: 200–208.
Bottenstein JE, Sato GH . Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc Natl Acad Sci USA 1979; 76: 514–517.
Takahashi M, Palmer TD, Takahashi J, Gage FH . Widespread integration and survival of adult-derived neural progenitor cells in the developing optic retina. Mol Cell Neurosci 1998; 12: 340–348.
Song H, Stevens CF, Gage FH . Astroglia induce neurogenesis from adult neural stem cells. Nature 2002; 417: 39–44.
Grynkiewicz G, Poenie M, Tsien RY . A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440–3450.
Acknowledgements
This work was supported by grants NSC 100-2321-B-010-005 from the National Science Council of Taiwan, ROC, and 101AC-B5 and 102AC-B5 from the Ministry of Education of Taiwan Aim for the Top University Plan.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Edited by A Verkhratsky
Supplementary Information accompanies this paper on Cell Death and Disease website
Supplementary information
Rights and permissions
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Tsao, HK., Chiu, PH. & Sun, S. PKC-dependent ERK phosphorylation is essential for P2X7 receptor-mediated neuronal differentiation of neural progenitor cells. Cell Death Dis 4, e751 (2013). https://doi.org/10.1038/cddis.2013.274
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cddis.2013.274
Keywords
This article is cited by
-
Neuroprotection of exercise: P2X4R and P2X7R regulate BDNF actions
Purinergic Signalling (2023)
-
Bilirubin represents a negative regulator of ILC2 in allergic airway inflammation
Mucosal Immunology (2022)
-
Cardiotoxin-induced skeletal muscle injury elicits profound changes in anabolic and stress signaling, and muscle fiber type composition
Journal of Muscle Research and Cell Motility (2020)
-
PKCγ promotes axonal remodeling in the cortico-spinal tract via GSK3β/β-catenin signaling after traumatic brain injury
Scientific Reports (2019)
-
P2RX7-MAPK1/2-SP1 axis inhibits MTOR independent HSPB1-mediated astroglial autophagy
Cell Death & Disease (2018)